11 Einträge gefunden

1. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

   1. Kluth, Martina
   2. Hesse, Jana
   3. Heinl, Anna
   4. Krohn, Antje
   5. Steurer, Stefan
   6. Sirma, Hüseyin
   7. Simon, Ronald

   2013 - Forschungsinformationssystem des UKE
2. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
3. Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.

   1. Alsdorf, Winfried H
   2. Clauditz, Till S
   3. Hoenig, Tobias
   4. Quaas, Alexander
   5. Sirma, Hüseyin
   6. Koenig, Alexandra M
   7. Izbicki, Jakob

   2013 - Forschungsinformationssystem des UKE
4. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

   1. Sirma, Hüseyin
   2. Broemel, Margarethe
   3. Stumm, Laura
   4. Tsourlakis, Maria Christina
   5. Steurer, Stefan
   6. Tennstedt, Pierre
   7. Salomon, Georg

   2013 - Forschungsinformationssystem des UKE
5. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
6. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

   1. Grupp, Katharina
   2. Diebel, Franz
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Breitmeyer, Karin
   6. Steurer, Stefan
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE
7. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

   1. Grupp, Katharina
   2. Sanader, Stella
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Koop, Christina
   6. Prien, Kristina
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
8. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE
9. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
10. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

    1. Jacobsen, Frank
    2. Ashtiani, Sharad Nouraie
    3. Tennstedt, Pierre
    4. Heinzer, Hans
    5. Simon, Ronald
    6. Sauter, Guido
    7. Sirma, Hüseyin

    2013 - Forschungsinformationssystem des UKE
11. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    1. Grupp, Katharina
    2. Höhne, Thorsten Simon
    3. Prien, Kristina
    4. Hube-Magg, Claudia
    5. Tsourlakis, Maria Christina
    6. Sirma, Hüseyin
    7. Pham, Taher

    2013 - Forschungsinformationssystem des UKE